Clinical Trial Update: Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease

View source ↗

Summary

A completed postmarketing surveillance study comparing handling and patient satisfaction of Berodual Respimat inhalation solution versus a powder inhaler in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Berodual Respimat (ipratropium bromide and fenoterol hydrobromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED